Skip to main content
. 2024 Aug 8;16(8):e66448. doi: 10.7759/cureus.66448

Table 5. Domain 4: Knowledge of the purpose of medication.

*Significant at p<0.05, **Significant at p<0.01. 

Knowledge of the purpose of medication          
Variable No (N (%)) Yes (N (%)) Total (N (%)) Χ2 p-value
Number of hospitalizations          
0 94 (91.3%) 9 (8.7%) 103 (100.0%) 12.765 0.002**
1 36 (97.3%) 1 (2.7%) 37 (100.0%)    
2 8 (80.0%) 2 (20.0%) 10 (100.0%)    
3 or >3 4 (50.0%) 4 (50.0%) 8 (100.0%)    
Total 142 (89.9%) 16 (10.1%) 158 (100.0%)    
No. of family members in care          
1 17 (81.0%) 4 (19.0%) 21 (100.0%) 7.892 0.034*
2 68 (94.4%) 4 (5.6%) 72 (100.0%)    
3 38 (82.6%) 8 (17.4%) 46 (100.0%)    
>3 19 (100.0%) 0 (0.0%) 19 (100.0%)    
Total 142 (89.9%) 16 (10.1%) 158 (100.0%)    
Variable Mean SD z p-value
Total duration of illness        
Knowledge of the purpose of medication        
No 8.86 5.61 −2.598 0.009**
Yes 14.69 9.16    
Total duration of treatment        
Knowledge of the purpose of medication        
No 7.34 5.16 −2.216 0.027*
Yes 12.38 9.05    
Scale for assessment of positive symptoms        
Knowledge of the purpose of medication        
No 18.27 15.94 −2.761 0.006**
Yes 32.75 19.98